A citation-based method for searching scientific literature

Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
Times Cited: 693







List of co-cited articles
471 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Fran├žoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
45

Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
Catherine Gorst, Chun Shing Kwok, Saadia Aslam, Iain Buchan, Evangelos Kontopantelis, Phyo K Myint, Grant Heatlie, Yoon Loke, Martin K Rutter, Mamas A Mamas. Diabetes Care 2015
218
13

Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.
Yoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, Toshiharu Ninomiya, Mark Cooper, Pavel Hamet, Giuseppe Mancia, Neil Poulter, Stephen Harrap, Mark Woodward,[...]. Diabetes Care 2014
173
12

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
589
11

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
604
11

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.
Katherine Esposito, Francesco Nappo, Raffaele Marfella, Giovanni Giugliano, Francesco Giugliano, Myriam Ciotola, Lisa Quagliaro, Antonio Ceriello, Dario Giugliano. Circulation 2002
10

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
10

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
131
10

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
9

Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
823
9




Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
8

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
8

Relative Hyperglycemia, a Marker of Critical Illness: Introducing the Stress Hyperglycemia Ratio.
Gregory W Roberts, Stephen J Quinn, Nyoli Valentine, Tariq Alhawassi, Hazel O'Dea, Stephen N Stranks, Morton G Burt, Matthew P Doogue. J Clin Endocrinol Metab 2015
61
11

Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial.
Jin J Zhou, Dawn C Schwenke, Gideon Bahn, Peter Reaven. Diabetes Care 2018
50
14



Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia.
Assam El-Osta, Daniella Brasacchio, Dachun Yao, Alessandro Pocai, Peter L Jones, Robert G Roeder, Mark E Cooper, Michael Brownlee. J Exp Med 2008
674
7


Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
7

Glucose "peak" and glucose "spike": Impact on endothelial function and oxidative stress.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael Ihnat, Jessica Thorpe, Roberto Testa, Anna Rita Bonfigli, Dario Giugliano. Diabetes Res Clin Pract 2008
58
12


Stress hyperglycaemia.
Kathleen M Dungan, Susan S Braithwaite, Jean-Charles Preiser. Lancet 2009
587
6

Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon Kim. Diabetes Metab J 2015
141
6


Glucose variability; does it matter?
Sarah E Siegelaar, Frits Holleman, Joost B L Hoekstra, J Hans DeVries. Endocr Rev 2010
271
6


Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky,[...]. Diabetes Care 2018
140
6

Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.
Alessandra Di Flaviani, Fabiana Picconi, Paola Di Stefano, Ilaria Giordani, Ilaria Malandrucco, Paola Maggio, Paola Palazzo, Fabrizio Sgreccia, Carlo Peraldo, Fabrizio Farina,[...]. Diabetes Care 2011
112
6

Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
Mee Kyoung Kim, Kyungdo Han, Yong-Moon Park, Hyuk-Sang Kwon, Gunseog Kang, Kun-Ho Yoon, Seung-Hwan Lee. Circulation 2018
71
8


Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou, Changsheng Ma. Cardiovasc Diabetol 2011
153
6



Glycemic variability: adverse clinical outcomes and how to improve it?
Zheng Zhou, Bao Sun, Shiqiong Huang, Chunsheng Zhu, Meng Bian. Cardiovasc Diabetol 2020
14
42

Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.
Jorik R Timmer, Miriam Hoekstra, Maarten W N Nijsten, Iwan C C van der Horst, Jan Paul Ottervanger, Robbert J Slingerland, Jan-Henk E Dambrink, Henk J G Bilo, Felix Zijlstra, Arnoud W J van 't Hof. Circulation 2011
151
5

Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study.
Angus Forbes, Trevor Murrells, Henrietta Mulnier, Alan J Sinclair. Lancet Diabetes Endocrinol 2018
67
7

Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study.
Justin B Echouffo-Tcheugui, Songzhu Zhao, Guy Brock, Roland A Matsouaka, David Kline, Joshua J Joseph. Diabetes Care 2019
40
12

Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
Jung A Kim, Ji Sung Lee, Hye Soo Chung, Eun Roh, You-Bin Lee, So-Hyeon Hong, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Sin Gon Kim,[...]. Diabetes Care 2018
21
23

Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
Anxin Wang, Xiaoxue Liu, Jie Xu, Xiaochen Han, Zhaoping Su, Shuohua Chen, Nan Zhang, Shouling Wu, Yongjun Wang, Yilong Wang. J Am Heart Assoc 2017
29
17

Visit-to-Visit Variations in Fasting Plasma Glucose and HbA1c Associated With an Increased Risk of Alzheimer Disease: Taiwan Diabetes Study.
Tsai-Chung Li, Chun-Pai Yang, Shih-Ting Tseng, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Kai-Lin Hwang, Sing-Yu Yang, Jen-Huai Chiang, Cheng-Chieh Lin. Diabetes Care 2017
38
13

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
199
5

Glucose variability: An emerging target for the treatment of diabetes mellitus.
Simona Frontoni, Paolo Di Bartolo, Angelo Avogaro, Emanuele Bosi, Giuseppe Paolisso, Antonio Ceriello. Diabetes Res Clin Pract 2013
85
5


The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention.
Yeoree Yang, Tae-Hoon Kim, Kun-Ho Yoon, Wook Sung Chung, Youngkeun Ahn, Myung-Ho Jeong, Ki-Bae Seung, Seung-Hwan Lee, Kiyuk Chang. Int J Cardiol 2017
25
20


Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, R C Turner. Diabetologia 1985
5

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Faramarz Ismail-Beigi, Timothy Craven, Mary Ann Banerji, Jan Basile, Jorge Calles, Robert M Cohen, Robert Cuddihy, William C Cushman, Saul Genuth, Richard H Grimm,[...]. Lancet 2010
795
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.